DIABNEXT

DIABNEXT

Set of connected devices and software that collect and analyze the main metrics of diabetes.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
*

N/A

Acquisition
Total Funding000k
Notes (0)
More about DIABNEXT
Made with AI
Edit

Diabnext is a healthcare technology company specializing in automated monitoring solutions for diabetics. The company operates in the medical devices and digital health market, providing tools that automatically record insulin and blood glucose levels. Diabnext serves both individual patients and healthcare providers by offering products like the DIABNEXT Pro, which allows for comprehensive data tracking and personalized therapeutic information. The business model is centered around the sale of its medical devices and subscription-based services for data management and patient care. Revenue is generated through direct sales of devices such as the Insulin Pen C3, various glucometers, and through ongoing service subscriptions for data management and patient monitoring.

Keywords: diabetes, insulin monitoring, blood glucose, medical devices, digital health, patient care, data management, healthcare providers, automated recording, therapeutic information.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo